Market Cap 97.31M
Revenue (ttm) 67.43M
Net Income (ttm) -165.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -245.94%
Debt to Equity Ratio 0.00
Volume 1,262,460
Avg Vol 1,640,860
Day's Range N/A - N/A
Shares Out 71.81M
Stochastic %K 9%
Beta 1.80
Analysts Sell
Price Target $6.27

Latest News on ZNTL

Zentalis Pharmaceuticals Announces Key Management Appointments

Dec 12, 2024, 7:00 AM EST - 4 months ago

Zentalis Pharmaceuticals Announces Key Management Appointments


FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc

Oct 7, 2024, 2:03 PM EDT - 6 months ago

FMR LLC Adjusts Its Stake in Zentalis Pharmaceuticals Inc